Commonwealth Equity Services LLC Has $20.17 Million Stock Holdings in iShares Biotechnology ETF $IBB

Commonwealth Equity Services LLC decreased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 22.7% in the 3rd quarter, HoldingsChannel reports. The fund owned 139,684 shares of the financial services provider’s stock after selling 40,935 shares during the period. Commonwealth Equity Services LLC’s holdings in iShares Biotechnology ETF were worth $20,166,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently modified their holdings of IBB. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $25,000. Berkshire Money Management Inc. bought a new position in iShares Biotechnology ETF in the second quarter worth $28,000. Financial Gravity Companies Inc. bought a new position in iShares Biotechnology ETF in the second quarter worth $29,000. Harbor Asset Planning Inc. acquired a new stake in iShares Biotechnology ETF during the second quarter worth $31,000. Finally, Trust Co. of Toledo NA OH bought a new stake in iShares Biotechnology ETF in the 2nd quarter valued at $32,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $172.39 on Friday. The firm has a fifty day moving average of $168.14 and a 200-day moving average of $149.84. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $179.64.

iShares Biotechnology ETF Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Tuesday, December 16th were given a $0.1831 dividend. This represents a $0.73 annualized dividend and a yield of 0.4%. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. The ex-dividend date of this dividend was Tuesday, December 16th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.